AI assistant
Tectonic Therapeutic, Inc. — Director's Dealing 2019
Jul 30, 2019
33251_dirs_2019-07-29_58b86120-39d1-4773-948c-cae53e162fd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVROBIO, Inc. (AVRO)
CIK: 0001681087
Period of Report: 2019-07-19
Reporting Person: Atlas Venture Opportunity Fund I, L.P. (See Remarks)
Reporting Person: Atlas Venture Associates Opportunity I, L.P. (See Remarks)
Reporting Person: Atlas Venture Associates Opportunity I, LLC (See Remarks)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 810811 | Indirect |
Footnotes
F1: The shares are held directly by Atlas Venture Opportunity Fund I, L.P. ("Atlas Venture Opportunity Fund I"). The general partner of Atlas Venture Opportunity Fund I is Atlas Venture Associates Opportunity I, L.P. ("AVAO I LP"). Atlas Venture Associates Opportunity I, LLC ("AVAO I LLC") is the general partner of AVAO I LP. Each of AVAO I LP and AVAO I LLC disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Opportunity Fund I, except to the extent of its pecuniary interest therein, if any.